Immunotherapy drug for cancer drugs from serious surgical interventions and hard therapies
When a person develops solid tumors in the stomach or esophagus or rectum, oncologists know how to treat them. But care often have serious effects on the quality of life. This may include the removal of the stomach or bladder, a permanent colostomy bag, radiation that makes patients infertile and last lasting from chemotherapy.So a research group at the Memorial Sloan Kettering Cancer Center, using a drug of the GSK pharmaceutical company, has tried something different.The researchers started with a group of 103 people. The participants in the study were between 2-3 percent of patients with cancer with tumors who should respond to immunotherapy, a drug that exceeds the barriers that prevent the immune system from attacking tumors.But in clinical studies, immunotherapy should not replace st...